Evaluation of safety of endoscopic submucosal dissection for gastric neoplasms without discontinuation of thienopyridine derivatives.

Not Applicable

• Conditions: Gastric neoplasms

• Registration Number: JPRN-UMIN000017078
• Lead Sponsor: The University of Tokyo

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2015-04-10
• Study Completion: 2016-11-28
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 10

Inclusion Criteria

Not provided

Exclusion Criteria

1) Double registration. 2) A past history of coronary stent embolism. 3) A stent located in left main coronary trunk. 4) A past history of irradiation in upper abdomen. 5) A plan of following treatment for esophageal or duodenal lesions. 6) A recent treatment for upper GI lesions within 28 days before registration. 7) A plan of following treatment for upper GI lesions within 28 days after treatment. 8) A systemic administration of steroids or anticoagulants. 9) An administration of NSAID or other antiplatelets that can be withdrawn before treatment. 10) Pregnancy or bleastfeeding. 11) An active bacterial or fungal infection. 12) A poor control of hypertension. 13) A severe respiratory disease. 14) Other conditions that are judged not suitable.

Study & Design

• Study Type: Interventional
• Study Design: Not specified